Does Rallies show 13F holders for MDT?

Yes. Rallies tracks hedge fund and 13F ownership data for MDT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MDT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.

MDT (Medtronic) Stock Analysis - Hedge Fund Holdings

Medtronic (MDT) is a publicly traded Healthcare sector company. As of May 20, 2026, MDT trades at $77.78 with a market cap of $99.27B and a P/E ratio of 21.02. MDT moved -0.65% today. Year to date, MDT is -18.19%; over the trailing twelve months it is -9.65%. Its 52-week range spans $74.40 to $106.33. Analyst consensus is buy with an average price target of $105.58. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MDT stock?

Hedge funds tracked by Rallies that own MDT include Panagora Asset, Chilton Investment, Bridgewater Associates, Sculptor Capital, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Medtronic.

MDT Key Metrics

Key financial metrics for MDT
Metric	Value
Price	$77.78
Market Cap	$99.27B
P/E Ratio	21.02
EPS	$3.72
Dividend Yield	0.71%
52-Week High	$106.33
52-Week Low	$74.40
Volume	7.66M
Avg Volume	0
Revenue (TTM)	$34.76B
Net Income	$4.79B
Gross Margin	65.51%

Top Hedge Funds Holding MDT

Panagora Asset holds 1.05M shares of MDT, changed +39.91% as of Mar 31, 2026.
Chilton Investment holds 498.32K shares of MDT, changed +89.64% as of Mar 31, 2026.
Bridgewater Associates holds 255.24K shares of MDT, changed -9.61% as of Mar 31, 2026.
Sculptor Capital holds 113.50K shares of MDT, changed +0.00% as of Sep 30, 2024.
Centerbook Partners holds 100.11K shares of MDT, changed +50.40% as of Mar 31, 2026.

Latest MDT News

Medtronic falls 3% as MiniMed insulin pump recalls weigh; shares hit 52-week low — Apr 29, 2026
Medtronic Acquires CathWorks for $585M, Expands AI-Driven FFRangio System — Apr 29, 2026
Medtronic’s Stealth AXiS Secures CE Mark for Spine, Cranial Robotics — Apr 28, 2026
Medtronic says cybersecurity breach contained, no disruption to products or finances — Apr 27, 2026
Medtronic’s Target Slashed to $95 as Perfusion Market Eyes $2.4B by 2034 — Apr 23, 2026

Recent MDT Insider Trades

KIIL HARRY SKIP sold 1.65K (~$161.27K) on Feb 19, 2026.
KIIL HARRY SKIP sold 30.57K (~$2.99M) on Feb 19, 2026.
KIIL HARRY SKIP sold 19.25K (~$1.88M) on Feb 19, 2026.

MDT Analyst Consensus

20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $105.58.

Common questions about MDT

Who owns MDT stock?: Hedge funds tracked by Rallies that own MDT include Panagora Asset, Chilton Investment, Bridgewater Associates, Sculptor Capital, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Medtronic.
Does Rallies show 13F holders for MDT?: Yes. Rallies tracks hedge fund and 13F ownership data for MDT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MDT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.